Want to see JP:6039 full AI Analyst Report?
6039 Stock Chart & Stats
¥1175.00
-¥12.00(-0.51%)
At close: 4:00 PM EST
¥1175.00
-¥12.00(-0.51%)
Day’s Range― - ―
52-Week Range¥875.00 - ¥1,605.00
Previous CloseN/A
Volume1.40K
Average Volume (3M)71.51K
Market Cap
¥14.50B
Enterprise Value¥17.45K
Total Cash (Recent Filing)¥1.25B
Total Debt (Recent Filing)¥5.16B
Price to Earnings (P/E)14.6
Beta0.80
Next Earnings
Oct 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.19%
Share Statistics
EPS (TTM)69.09
Shares Outstanding14,391,000
10 Day Avg. Volume48,520
30 Day Avg. Volume71,510
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)3.10
Price to Sales (P/S)2.44
P/FCF Ratio-15.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)75
Revenue Forecast (FY)¥6.82B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthRevenue has more than doubled over five fiscal years and still grew about 13% in FY2026. Sustained expansion indicates increasing demand for referral-based advanced animal care and provides operating scale that can support continued earnings growth.
Improving Net IncomeRising net income alongside strong revenue growth shows that the company is converting expanding demand into greater absolute earnings. This strengthens its ability to reinvest in specialist services, equipment and capacity over the medium term.
Positive Operating Cash FlowConsistently positive and improving operating cash flow indicates that core veterinary operations generate cash before investment needs. This provides an internal funding base for expansion, even though free-cash-flow conversion remains uneven.
Bears Say
Volatile Free Cash FlowThe sharp deterioration in free cash flow suggests that expansion spending or working-capital requirements can absorb operating cash. Repeated historical volatility reduces confidence in near-term self-funded growth and may increase reliance on financing.
Higher Debt BurdenThe FY2026 debt step-up raises financial risk just as free cash flow turns negative. Higher interest and repayment obligations could constrain investment flexibility, while leverage may become more sensitive to any slowdown in specialist case volumes.
Variable Profit MarginsAlthough earnings are growing, historical margins have varied and current-period margin detail is unavailable. This limits visibility into whether growth is structurally improving profitability or being offset by staffing, equipment and treatment-delivery costs.
Japan Animal Referral Medical Center Co., Ltd. News
6039 FAQ
What was Japan Animal Referral Medical Center Co., Ltd.’s price range in the past 12 months?
Japan Animal Referral Medical Center Co., Ltd. lowest stock price was ¥875.00 and its highest was ¥1605.00 in the past 12 months.
What is Japan Animal Referral Medical Center Co., Ltd.’s market cap?
Japan Animal Referral Medical Center Co., Ltd.’s market cap is ¥14.50B.
When is Japan Animal Referral Medical Center Co., Ltd.’s upcoming earnings report date?
Japan Animal Referral Medical Center Co., Ltd.’s upcoming earnings report date is Oct 30, 2026 which is in 43 days.
How were Japan Animal Referral Medical Center Co., Ltd.’s earnings last quarter?
Japan Animal Referral Medical Center Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ¥18.54 earnings per share for the quarter.
Is Japan Animal Referral Medical Center Co., Ltd. overvalued?
According to Wall Street analysts Japan Animal Referral Medical Center Co., Ltd.’s price is currently Overvalued.
Does Japan Animal Referral Medical Center Co., Ltd. pay dividends?
Japan Animal Referral Medical Center Co., Ltd. pays a Annually dividend of ¥13 which represents an annual dividend yield of 1.19%. See more information on Japan Animal Referral Medical Center Co., Ltd. dividends here
What is Japan Animal Referral Medical Center Co., Ltd.’s EPS estimate?
Japan Animal Referral Medical Center Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Animal Referral Medical Center Co., Ltd. have?
Japan Animal Referral Medical Center Co., Ltd. has 14,391,000 shares outstanding.
What happened to Japan Animal Referral Medical Center Co., Ltd.’s price movement after its last earnings report?
Japan Animal Referral Medical Center Co., Ltd. reported an EPS of ¥18.54 in its last earnings report. Following the earnings report the stock price went down -0.444%.
Which hedge fund is a major shareholder of Japan Animal Referral Medical Center Co., Ltd.?
Currently, no hedge funds are holding shares in JP:6039
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Animal Referral Medical Center Co., Ltd.
Japan Animal Referral Medical Center Co., Ltd. operates a network of animal medical facilities across Japan, specializing in delivering advanced veterinary care for dogs and cats. These comprehensive centers boast an extensive range of specialized departments, from cardiology, respiratory, urology, and gastroenterology to oncology, neurology, orthopedics, ophthalmology, diagnostic imaging, and anesthesiology. Beyond direct patient care, the company also offers professional training, encompassing clinical instruction and treatment practices. Furthermore, it actively engages in research and development initiatives, exploring fields such as genetic testing, immunotherapy, and regenerative medicine. The firm, established in 2005, has its headquarters located in Kawasaki, Japan.